logo-loader

Aduro Biotech

Receive alerts
Market:
NASDAQ
Market Cap:
$87.76 m
Price
1.09 USD
Change
-3.13%
52 weeks high
4.59
52 weeks low
0.90

In brief

Aduro is dedicated to its mission to discover, develop, and commercialize immunotherapies that transform the treatment of challenging diseases, including cancer.

To fulfill its mission, the company is advancing several leading-edge proprietary technologies that are designed to initiate and sustain the immune system to mobilize and attack tumors. Collectively, Aduro’s technologies are uniquely positioned to recruit and direct the immune system by activating cancer-fighting immune cells and inhibiting immune suppressive cells known to allow tumor growth.